Most recently, GLP-1 drugs have blown through everyone's health care budgets. As the articles state, insurers are scurrying to remove as much coverage for them as they can. Of course, if we had a real market in prescription drugs - one where the most power buyers were actually allowed to use their leverage, the price probably would have come down by now.